AsianScientist (May 20, 2015) – DKSH Business Unit Healthcare, a partner for healthcare companies seeking to grow their businesses in Asia, has signed an agreement to provide marketing, sales, logistics, distribution, credit management and collection services to Pfizer in Laos.
Under the agreement, DKSH has been appointed as the sole Market Expansion Services provider for Pfizer’s entire range of pharmaceutical products in Laos. The agreement is an extension of the successful regional collaboration that also includes Cambodia and Thailand.
“We believe our partnership with DKSH will translate into wider and easier access to our high-quality medicines in Laos, so that more people will benefit from our healthcare innovations. We chose DKSH as it has a well-established nationwide infrastructure in Laos, well-trained local staff and an in-depth understanding of the Lao healthcare market. Moreover, their expertise in marketing and sales as well as their dedication to compliance and quality will mean better services to our patients and business partners,” said Mr. Christian Malherbe, country lead, Pfizer Thailand & Indochina.
“South East Asian markets such as Laos provide extensive opportunities for multinational companies like Pfizer. With our in-depth industry expertise and nearly 20 years’ experience in delivering Market Expansion Services in Laos, we are committed to growing Pfizer’s brand in this market,” commented Mr. Kentaro Imamoto, general manager, Business Unit Healthcare, DKSH Laos.
———
Source: DKSH.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.